Abstract
Although endothelial cells are not immunological cells in sensu stricto, they play an important role in controlling inflammation/immune responses. The endothelium is involved in a wide range of pathologies, the most common being vascular diseases and cancer, and they also are central to transplant rejection. Genetic modification of endothelium allows different strategies for inducing tolerance, modulating inflammation, stimulating the immune response or inhibiting the formation of new blood vessels. In this context, the lack of effective and specific pharmacological interventions renders endothelial cells extremely attractive for gene therapy applications. Despite efforts made to genetically modify endothelial cells, the results obtained have suffered from the differences of the endothelium at the different anatomical sites. Several studies are currently being developed to specifically target endothelium using viral and non viral gene delivery approaches. We highlight here some strategies used for genetically manipulating endothelial cells with the aim of inducing tolerance to allograft, or enhancing immunity and/or inhibiting uncontrolled endothelial cell proliferation in tumours.
Keywords: Endothelial cells, gene transfer, gene delivery, inflammation, immune response
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Modulation of the Immune Response by Targeting Endothelial Cells
Volume: 6 Issue: 2
Author(s): Maria Manunta, Peng Hong Tan and Andrew John Timothy George
Affiliation:
Keywords: Endothelial cells, gene transfer, gene delivery, inflammation, immune response
Abstract: Although endothelial cells are not immunological cells in sensu stricto, they play an important role in controlling inflammation/immune responses. The endothelium is involved in a wide range of pathologies, the most common being vascular diseases and cancer, and they also are central to transplant rejection. Genetic modification of endothelium allows different strategies for inducing tolerance, modulating inflammation, stimulating the immune response or inhibiting the formation of new blood vessels. In this context, the lack of effective and specific pharmacological interventions renders endothelial cells extremely attractive for gene therapy applications. Despite efforts made to genetically modify endothelial cells, the results obtained have suffered from the differences of the endothelium at the different anatomical sites. Several studies are currently being developed to specifically target endothelium using viral and non viral gene delivery approaches. We highlight here some strategies used for genetically manipulating endothelial cells with the aim of inducing tolerance to allograft, or enhancing immunity and/or inhibiting uncontrolled endothelial cell proliferation in tumours.
Export Options
About this article
Cite this article as:
Manunta Maria, Hong Tan Peng and John Timothy George Andrew, Modulation of the Immune Response by Targeting Endothelial Cells, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (2) . https://dx.doi.org/10.2174/187152307780598045
DOI https://dx.doi.org/10.2174/187152307780598045 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer’s Disease
Current Neuropharmacology Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Current Pharmaceutical Design Marine Collagen as a Source of Bioactive Molecules: A Review
The Natural Products Journal Editorial [ Angiogenesis: A Promising Treatment Option for Peripheral Arterial Disease ]
Current Vascular Pharmacology Metabolic Syndrome and Diabetic Atherothrombosis: Implications in Vascular Complications
Current Molecular Medicine Laser Modified Phenothiazines and Hydantoins: Photo-products Characterisation and Application on Animal Eyes Pseudo-tumours
Letters in Drug Design & Discovery Gender Differences in Response to Therapy for Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine White Matter Integrity in Subcortical Vascular Cognitive Impairment: A Multimodal Structural MRI Study
Current Alzheimer Research Dynamic Role of Macrophage Sub Types on Development of Atherosclerosis and Potential Use of Herbal Immunomodulators as Imminent Therapeutic Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry Inflammation in Peripheral Arterial Disease (PAD)
Current Pharmaceutical Design Inflammasome Signaling and Other Factors Implicated in Atherosclerosis Development and Progression
Current Pharmaceutical Design Mitochondria as Possible Pharmaceutical Targets for the Effects of Vitamin E and its Homologues in Oxidative Stress-Related Diseases
Current Pharmaceutical Design The Triad: Erectile Dysfunction - Endothelial Dysfunction - Cardiovascular Disease
Current Pharmaceutical Design Therapeutic Drugs that Behave as Mechanism-Based Inhibitors of Cytochrome P450 3A4
Current Drug Metabolism The Effects of Lipid-Regulating Therapy on Haemostatic Parameters
Current Pharmaceutical Design Editorial: microRNAs: Potential Targets for the Treatment of Cardiovascular Disease
Current Vascular Pharmacology Implications of the Molecular Basis of Prostacyclin Biosynthesis and Signaling in Pharmaceutical Designs
Current Pharmaceutical Design Non-Alcoholic Fatty Liver Disease and Vascular Disease
Current Vascular Pharmacology Cerebral Artery Signal Transduction Mechanisms: Developmental Changes in Dynamics and Ca<sup>2+</sup> Sensitivity
Current Vascular Pharmacology Mitochondria-Targeted Antioxidant Peptides
Current Pharmaceutical Design